Found: 11
Select item for more details and to access through your institution.
First‐in‐human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 4, p. 1047, doi. 10.1007/s10637-021-01081-x
- By:
- Publication type:
- Article
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 6, p. 1060, doi. 10.1007/s10637-018-0625-6
- By:
- Publication type:
- Article
A phase IIa study of HA-irinotecan, formulation of hyaluronic acid and irinotecan targeting CD44 in extensive-stage small cell lung cancer.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 2, p. 288, doi. 10.1007/s10637-017-0555-8
- By:
- Publication type:
- Article
A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 10, p. 1608, doi. 10.1038/s41416-023-02431-7
- By:
- Publication type:
- Article
A Phase 1/2 study of the PD-L1 inhibitor, BGB-A333, alone and in combination with the PD-1 inhibitor, tislelizumab, in patients with advanced solid tumours.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1418, doi. 10.1038/s41416-022-02128-3
- By:
- Publication type:
- Article
Recruitment, outcomes, and toxicity trends in phase I oncology trials: Six-year experience in a large institution.
- Published in:
- Cancer Reports, 2022, v. 5, n. 2, p. 1, doi. 10.1002/cnr2.1465
- By:
- Publication type:
- Article
Impact of Radiotherapy on the Efficacy and Toxicity of anti-PD-1 Inhibitors in Metastatic NSCLC.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. e425, doi. 10.1016/j.cllc.2020.06.001
- By:
- Publication type:
- Article
Is there a role for combined anti–PD‐1/CTLA‐4 checkpoint blockade in the management of advanced biliary tract cancers?
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 1129, doi. 10.1002/cncr.34660
- By:
- Publication type:
- Article
Leveraging Comprehensive Cancer Registry Data to Enable a Broad Range of Research, Audit and Patient Support Activities.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4131, doi. 10.3390/cancers14174131
- By:
- Publication type:
- Article
Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Biomarkers in colorectal cancer.
- Published in:
- Clinical & Translational Oncology, 2010, v. 12, n. 4, p. 261, doi. 10.1007/s12094-010-0502-z
- By:
- Publication type:
- Article